Dronedarone in patients with congestive heart failure: insights from ATHENA

Stefan H Hohnloser; Harry J G M Crijns; Martin van Eickels; Christophe Gaudin; Richard L Page; Christian Torp-Pedersen; Stuart J Connolly; ATHENA Investigators

doi:10.1093/eurheartj/ehq113

Dronedarone in patients with congestive heart failure: insights from ATHENA

Stefan H Hohnloser, Harry J G M Crijns, Martin van Eickels, Christophe Gaudin, Richard L Page, Christian Torp-Pedersen, Stuart J Connolly, ATHENA Investigators

66 Citations (Scopus)

Abstract

Dronedarone is a new multichannel blocking antiarrhythmic drug for treatment of atrial fibrillation (AF). In patients with recently decompensated congestive heart failure (CHF) and depressed LV function, the drug was associated with excess mortality compared with a placebo group. The present study aimed to analyse in detail the effects of dronedarone on mortality and morbidity in AF patients CHF.

Original language	English
Journal	European Heart Journal
Volume	31
Issue number	14
Pages (from-to)	1717-21
Number of pages	5
ISSN	0195-668X
DOIs	https://doi.org/10.1093/eurheartj/ehq113
Publication status	Published - 1 Jul 2010

Access to Document

10.1093/eurheartj/ehq113

Cite this

@article{be1b1b448fe34bde9cb5ee0623ba52c2,

title = "Dronedarone in patients with congestive heart failure: insights from ATHENA",

abstract = "Dronedarone is a new multichannel blocking antiarrhythmic drug for treatment of atrial fibrillation (AF). In patients with recently decompensated congestive heart failure (CHF) and depressed LV function, the drug was associated with excess mortality compared with a placebo group. The present study aimed to analyse in detail the effects of dronedarone on mortality and morbidity in AF patients CHF.",

author = "Hohnloser, \{Stefan H\} and Crijns, \{Harry J G M\} and \{van Eickels\}, Martin and Christophe Gaudin and Page, \{Richard L\} and Christian Torp-Pedersen and Connolly, \{Stuart J\} and \{ATHENA Investigators\}",

year = "2010",

month = jul,

day = "1",

doi = "10.1093/eurheartj/ehq113",

language = "English",

volume = "31",

pages = "1717--21",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "14",

}

TY - JOUR

T1 - Dronedarone in patients with congestive heart failure: insights from ATHENA

AU - Hohnloser, Stefan H

AU - Crijns, Harry J G M

AU - van Eickels, Martin

AU - Gaudin, Christophe

AU - Page, Richard L

AU - Torp-Pedersen, Christian

AU - Connolly, Stuart J

AU - ATHENA Investigators

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Dronedarone is a new multichannel blocking antiarrhythmic drug for treatment of atrial fibrillation (AF). In patients with recently decompensated congestive heart failure (CHF) and depressed LV function, the drug was associated with excess mortality compared with a placebo group. The present study aimed to analyse in detail the effects of dronedarone on mortality and morbidity in AF patients CHF.

AB - Dronedarone is a new multichannel blocking antiarrhythmic drug for treatment of atrial fibrillation (AF). In patients with recently decompensated congestive heart failure (CHF) and depressed LV function, the drug was associated with excess mortality compared with a placebo group. The present study aimed to analyse in detail the effects of dronedarone on mortality and morbidity in AF patients CHF.

UR - https://www.scopus.com/pages/publications/77954828276

U2 - 10.1093/eurheartj/ehq113

DO - 10.1093/eurheartj/ehq113

M3 - Journal article

C2 - 20436046

SN - 0195-668X

VL - 31

SP - 1717

EP - 1721

JO - European Heart Journal

JF - European Heart Journal

IS - 14

ER -

Dronedarone in patients with congestive heart failure: insights from ATHENA

Abstract

Access to Document

Other files and links

Fingerprint

Cite this